(19)
(11) EP 4 213 937 A1

(12)

(43) Date of publication:
26.07.2023 Bulletin 2023/30

(21) Application number: 21782434.1

(22) Date of filing: 14.09.2021
(51) International Patent Classification (IPC): 
A61P 3/00(2006.01)
A61K 31/4985(2006.01)
 A61K 9/20(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/2054; A61K 9/2095; A61K 31/4985; A61P 3/00
(86) International application number:
PCT/EP2021/025344
(87) International publication number:
WO 2022/058044 (24.03.2022 Gazette 2022/12)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 15.09.2020 GR 20200100560

(71) Applicant: Pharmathen S.A.
15351 Pallini Attikis (GR)

(72) Inventors:
  • KARAVAS, Evangelos
    153 51 Pallini Attikis (GR)
  • KOUTRIS, Efthymios
    153 51 Pallini Attikis (GR)
  • SAMARA, Vasiliki
    153 51 Pallini Attikis (GR)
  • KOUTRI, Ioanna
    153 51 Pallini Attikis (GR)
  • KALASKANI, Anastasia
    153 51 Pallini Attikis (GR)
  • KAKOURIS, Andreas
    153 51 Pallini Attikis (GR)
  • FOUSTERIS, Manolis
    153 51 Pallini Attikis (GR)

   


(54) SOLID DOSAGE FORM COMPRISING SITAGLIPTIN AND METHOD OF PREPARATION THEREOF